Follow on Google News News By Tag * Regenerative Medicine * Stem Cells * Commercialization Of Regenerative Medicine * Cell Therapies * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Regenerative Medicine Field Still Faces Great Hurdles on the Road to CommercializationIQPC’s Commercialization of Regenerative Medicine Conference focuses on surmounting challenges faced by the industry
By: Taryn Soltysiak There are currently over 2,000 clinical trials linked to cell therapies, however there are significant commercialization challenges to surmount before companies see any return on their investments. The path to commercialization includes optimization of clinical development, negotiating reimbursement, overcoming strategic and regulatory challenges, and navigating partnership opportunities. Speaking on the commercial manufacturing scale-up process and some factors involved in the process, William Fodor, Director of Translational Sciences, Cell Therapy Group, noted the many approval processes and pitfalls to be aware of within the scale-up process. Read the interview in its entirety here: http://www.regenerativemedicinesummit.com/ Some specific aspects of the commercialization of regenerative medicine addressed on the conference agenda include: • Approval processes and pitfalls within the scale-up process • Developing a sound business plan • Case studies from companies who have successfully raised funds • Using stem cells in a commercial and industrial setting • Analysis of regulatory pathways and pre-market approval • Panel discussions comparing four evolving business models Featured speakers include industry leaders Claudia Zylberberg, PhD, President and CEO of Akron Biotechnology; For more information on the Commercialization of Regenerative Medicine Conference please visit http://www.regenerativemedicinesummit.com or contact Robert Littlefield, Program Director at Robert.Littlefield@ # # # IQPC (www.iqpc.com) End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|